Rani Therapeutics Holdings, Inc. ·

RANI 8-K 2026-06-29

Rani Therapeutics Holdings, Inc. (RANI) 8-K dated 2026-06-29 — accession 0001856725-26-000003. This URL is the filing, not the RANI hub.

Rani Therapeutics Holdings, Inc. (RANI) is a biotechnology company listed on US.

Rani Therapeutics Holdings, Inc. filed a 8-K on 2026-06-29. Accession 0001856725-26-000003.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.

Not investment advice. The RANI SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR